The CNIO and Hospital 12 de Octubre find a potential new combination therapy against a rare disease of the bone marrow

by CNIO - Centro Nacional de Investigaciones Oncológicas

Myelofibrosis is a very rare serious disease that affects bone marrow stem cells. The average survival of these patients, with treatment, is about five years. The new study, published in the journal '...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A dietary supplement has beneficial effe...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...

Photos Stream